Question to the Department for Business, Energy and Industrial Strategy:

To ask the Secretary of State for Business, Energy and Industrial Strategy, how many covid-19 vaccine doses England has available for use in reserve supply.

The UK Government has secured early access to 397 million vaccine doses through supply agreements with six separate vaccine developers, of which four have received regulatory approval and three are currently in deployment. This includes agreements with:

• Pfizer/BioNTech for 100 million doses
• University of Oxford/AstraZeneca for 100 million doses
• Moderna for 17 million doses
• Novavax for 60 million doses
• Janssen for 20 million doses
• Valneva for 100 million doses

In addition, the Government has a reservation agreement with GlaxoSmithKline/Sanofi Pasteur for 60 million doses and a non-binding agreement with CureVac for 50 million doses.

We are in constant contact with the vaccine manufacturers and are confident that the supply of vaccines to the UK will not be disrupted and that we will meet the vaccination targets set out by my Rt. Hon. Friend the Prime Minister on 14 June:

• All adults aged 18 and over to be offered a first dose by 19 July, 2 weeks earlier than planned.
• By 19 July, all those aged over 50 and the clinically extremely vulnerable to have been offered their second dose.
• Second doses for all over 40s will be accelerated by reducing the dosing interval from 12 weeks to 8 weeks. All over 40s who received a first dose by mid-May will be offered a second dose by 19 July.